Top story

Building Confidence in African Traditional Medicines

NAIROBI, 31 August 2026 — African traditional medicines remain an integral part of society and healthcare, but unlocking their full potential requires stronger quality assurance, safety monitoring, scientific evidence, accurate dosing, standardised production and …

Read full story

FDA Approves Yartemlea (narsoplimab-wuug) for the Treatment of Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy

Drugs.com - New Drug Approvals

Wed, 24 Dec 2025

MediNatura New Mexico, Inc. Issues Voluntary Nationwide Recall of ReBoost Nasal Spray Due to Microbial Contamination

Drugs.com - FDA MedWatch Drug Alerts

Wed, 10 Dec 2025

International Day of Persons with Disabilities Day 2025

WHO Regional Office for Africa

By mtabi@who.int - Tue, 02 Dec 2025

U.S. Announces Negotiated Prices for 15 Drugs Under Medicare

The New York Times - Drugs & Pharmaceuticals

By Rebecca Robbins - Wed, 26 Nov 2025

Postpartum Prescription of GLP-1 Drugs Has Increased Sharply, Study Finds

The New York Times - Drugs & Pharmaceuticals

By Roni Caryn Rabin - Wed, 26 Nov 2025

FDA Grants Accelerated Approval for Voyxact (sibeprenlimab-szsi) for the Reduction of Proteinuria in Adults with Primary Immunoglobulin A Nephropathy (IgAN) at Risk for Disease Progression

Drugs.com - New Drug Approvals

Wed, 26 Nov 2025

FDA Grants Accelerated Approval for Voyxact (sibeprenlimab-szsi) for the Reduction of Proteinuria in Adults with Primary Immunoglobulin A Nephropathy

Drugs.com - New Drug Approvals

Wed, 26 Nov 2025

U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Drugs.com - Clinical Trial Results

Wed, 26 Nov 2025

Eylea HD (aflibercept) Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications

Drugs.com - New Drug Approvals

Wed, 19 Nov 2025